Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vericel Corp (VCEL)  
$48.10 0.55 (1.13%) as of 4:30 Fri 5/10


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 52,373,000
Market Cap: 2.52(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $30.85 - $52.9
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  474
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 134,738 259,234 263,234 303,833
Total Sell Value $6,189,261 $10,761,080 $10,907,920 $12,010,179
Total People Sold 5 7 7 7
Total Sell Transactions 12 29 31 34
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 394
  Page 5 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Siegal Jonathan Principal Accounting Officer   •       •      –    2023-02-18 4 OE $0.00 $0 D/D 419 1,094     -
   Halpin Michael Chief Operating Officer   •       •      –    2023-02-18 4 D $29.82 $39,720 D/D (1,332) 14,764     -
   Halpin Michael Chief Operating Officer   •       •      –    2023-02-18 4 OE $0.00 $0 D/D 2,813 16,096     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2023-02-18 4 D $29.82 $33,041 D/D (1,108) 51,414     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2023-02-18 4 OE $0.00 $0 D/D 2,325 52,522     -
   Flynn Sean C. SVP, General Counsel   •       •      –    2023-02-18 4 D $29.82 $34,442 D/D (1,155) 5,258     -
   Flynn Sean C. SVP, General Counsel   •       •      –    2023-02-18 4 OE $0.00 $0 D/D 2,325 6,413     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       •      –    2023-02-18 4 D $29.82 $31,758 D/D (1,065) 13,697     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       •      –    2023-02-18 4 OE $0.00 $0 D/D 2,754 14,762     -
   Colangelo Dominick President and CEO   •       •      –    2023-02-18 4 OE $0.00 $0 D/D 11,700 176,436     -
   Colangelo Dominick President and CEO   •       •      –    2023-02-18 4 D $29.82 $161,714 D/D (5,423) 171,013     -
   Halpin Michael Chief Operating Officer   •       •      –    2023-02-11 4 D $29.30 $58,102 D/D (1,983) 13,283     -
   Halpin Michael Chief Operating Officer   •       •      –    2023-02-11 4 OE $0.00 $0 D/D 3,500 15,266     -
   Colangelo Dominick President and CEO   •       •      –    2023-02-11 4 D $29.30 $102,990 D/D (3,515) 164,736     -
   Colangelo Dominick President and CEO   •       •      –    2023-02-11 4 OE $0.00 $0 D/D 7,500 168,251     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2023-02-11 4 D $29.30 $24,612 D/D (840) 50,197     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2023-02-11 4 OE $0.00 $0 D/D 1,625 51,037     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2023-02-06 4 D $30.60 $9,486 D/D (310) 49,412     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2023-02-06 4 OE $0.00 $0 D/D 650 49,722     -
   Colangelo Dominick President and CEO   •       •      –    2023-02-06 4 D $30.60 $99,542 D/D (3,253) 160,751     -
   Colangelo Dominick President and CEO   •       •      –    2023-02-06 4 OE $0.00 $0 D/D 6,938 164,004     -
   Halpin Michael Chief Operating Officer   •       •      –    2023-02-06 4 D $30.60 $30,233 D/D (988) 11,766     -
   Halpin Michael Chief Operating Officer   •       •      –    2023-02-06 4 OE $0.00 $0 D/D 1,875 12,754     -
   Siegal Jonathan Principal Accounting Officer   •       •      –    2023-02-02 4 AS $31.00 $10,230 D/D (330) 675 9%     
   Colangelo Dominick President and CEO   •       •      –    2023-01-10 4 AS $27.13 $1,083,598 D/D (39,938) 157,066 17%     
  394 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us